These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35042424)

  • 1. Challenges in the market access of regenerative medicines, and implications for manufacturers and decision-makers: a systematic review.
    Qiu T; Pochopień M; Hanna E; Liang S; Wang Y; Han R; Toumi M; Aballéa S
    Regen Med; 2022 Mar; 17(3):119-139. PubMed ID: 35042424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal.
    Hettle R; Corbett M; Hinde S; Hodgson R; Jones-Diette J; Woolacott N; Palmer S
    Health Technol Assess; 2017 Feb; 21(7):1-204. PubMed ID: 28244858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation.
    Claxton L; Simmonds M; Beresford L; Cubbon R; Dayer M; Gottlieb SS; Hartshorne-Evans N; Kilroy B; Llewellyn A; Rothery C; Sharif S; Tierney JF; Witte KK; Wright K; Stewart LA
    Health Technol Assess; 2022 Jan; 26(4):1-128. PubMed ID: 35076012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
    Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
    Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement.
    Kim DS; Lee G; Cho H; Bae S
    Front Bioeng Biotechnol; 2021; 9():737504. PubMed ID: 34527662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
    Crathorne L; Huxley N; Haasova M; Snowsill T; Jones-Hughes T; Hoyle M; Briscoe S; Coelho H; Long L; Medina-Lara A; Mujica-Mota R; Napier M; Hyde C
    Health Technol Assess; 2016 Feb; 20(13):1-588, v-vi. PubMed ID: 26907163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
    Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
    Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
    Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
    Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation.
    Brazzelli M; Javanbakht M; Imamura M; Hudson J; Moloney E; Becker F; Wallace S; Omar MI; Shimonovich M; MacLennan G; Ternent L; Vale L; Montgomery I; Mackie P; Saraswat L; Monga A; Craig D
    Health Technol Assess; 2019 Mar; 23(14):1-306. PubMed ID: 30929658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing access to advanced therapy medicinal products: Challenges for NHS Wales.
    Champion AR; Lewis S; Davies S; Hughes DA
    Br J Clin Pharmacol; 2021 Jun; 87(6):2444-2449. PubMed ID: 32495405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
    Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J
    Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare.
    Jönsson B; Hampson G; Michaels J; Towse A; von der Schulenburg JG; Wong O
    Eur J Health Econ; 2019 Apr; 20(3):427-438. PubMed ID: 30229376
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.